Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Tech World.
Press releases published on May 8, 2025
Paul Schaus of CCG Catalyst Consulting Named Among Top 25 Financial Services Consultants and Leaders of 2025
EIN Presswire
·
May 8, 2025
Paul Schaus of CCG Catalyst recognized for guiding banks, credit unions, and fintechs through transformations and fostering innovation in financial services. PHOENIX, AZ, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- also the Founder of the Bankers …
Global Artificial Intelligence (Ai) In Media Market Outlook 2025-2034: Growth Drivers, Share, And Trends
EIN Presswire
·
May 8, 2025
The Business Research Company's Global Artificial Intelligence (Ai) In Media Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 8, 2025 /EINPresswire.com/ -- The Business Research Company’ …
The 4-Acetylbenzonitrile Global Market Report Outlines Significant Growth and Key Market Trends
EIN Presswire
·
May 8, 2025
The Business Research Company's 4-Acetylbenzonitrile Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 8, 2025 /EINPresswire.com/ -- How Does The 4-Acetylbenzonitrile Market …
Aerospace & Industrial Ignition Systems And Aircraft Ignition System Market Forecast 2025–2034: Growth Drivers & Trends
EIN Presswire
·
May 8, 2025
The Business Research Company's Aerospace …
Draganfly Announces First Quarter Results of 2025
GlobeNewswire
·
May 8, 2025
Vancouver, BC., May 08, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is pleased to announce its first quarter …
Tarsus to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 8, 2025
IRVINE, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today announced that management plans to participate in the following upcoming investor conferences: Bank of America Securities 2025 Health Care Conference on …
Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering
GlobeNewswire
·
May 8, 2025
Hopewell, New Jersey, May 08, 2025 (GLOBE NEWSWIRE) -- Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds” or the “Company”), a clinical stage biopharmaceutical company that is in the process of developing Apitox, an intradermally …
BioSyent Schedules First Quarter Earnings Release for May 15, 2025
GlobeNewswire
·
May 8, 2025
MISSISSAUGA, Ontario, May 08, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months ended March 31, 2025 on Thursday, May 15, 2025 after market hours. A presentation …
Galecto Reports First Quarter 2025 Operating and Financial Results
GlobeNewswire
·
May 8, 2025
BOSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, announced its operating and financial results for the quarter …
Theriva Biologics Announces Closing of $7.5 Million Public Offering
GlobeNewswire
·
May 8, 2025
ROCKVILLE, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, …
Serina Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights
GlobeNewswire
·
May 8, 2025
On track for first patient dosing of SER-252 in Phase 1b clinical trial in advanced Parkinson’s disease in Q4 2025 Strengthened balance sheet with recent financing Advancing innovative POZ Platform across multiple therapeutic modalities Two new seasoned …
Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
Data cutoff date for Phase 2b NAVIGATE trial efficacy reached on April 30, 2025; top-line data readout expected in late June 2025 Nature Microbiology publication highlights preclinical data and the potential of CD388 as a potent, universal antiviral for …
PacBio Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
MENLO PARK, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2025. First quarter results: Q1 2025 Q1 2024 Revenue $37.2 million $38.8 million Instrument revenue $11.0 million …
Microchip Technology Announces Quarterly Cash Dividend on Common Stock of 45.5 Cents Per Share
GlobeNewswire
·
May 8, 2025
CHANDLER, Ariz., May 08, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that its Board of Directors declared a quarterly cash …
Microchip Technology Announces Financial Results For Fourth Quarter and Fiscal Year 2025
GlobeNewswire
·
May 8, 2025
For the quarter ended March 31, 2025 Net sales of $970.5 million, declined 5.4% sequentially and 26.8% from the year ago quarter. The midpoint of our guidance provided on February 6, 2025 was net sales of $960.0 million. On a GAAP basis: gross profit of …
INmune Bio Inc. Announces First Quarter 2025 Results and Provides Business Update
GlobeNewswire
·
May 8, 2025
BOCA RATON, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage biotechnology company targeting inflammation and immunology through the innate immune system, today announces its financial results for the …
PubMatic Announces First Quarter 2025 Financial Results; Board of Directors Authorizes $100M Expansion of Share Repurchase Program
GlobeNewswire
·
May 8, 2025
Delivered revenue and adjusted EBITDA ahead of guidance; Revenue from omnichannel video, including CTV, grew 20% and was 40% of total revenue; CTV revenue grew over 50% year-over-year; and Supply Path Optimization represented a record 55%+ of total …
Oculis Reports Q1 2025 Financial Results and Provides Company Update
GlobeNewswire
·
May 8, 2025
The recent R…
Taysha Gene Therapies to Release First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15
GlobeNewswire
·
May 8, 2025
DALLAS, May 08, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system ( …
Zymeworks Provides Corporate Update and Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
Six posters presented at the American Association for Cancer Research (AACR) annual meeting Appointment of Dr. Sabeen Mekan as Senior Vice President, Clinical Development Reported $321.6 million in cash resources as of March 31, 2025 (compared to $324.2 …